(Q51019075)

27 March 2018

title

EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. (English)

1 reference

27 March 2018

author

Simona Inghilleri

3

1 reference

27 March 2018

Roberto Dore

9

1 reference

27 March 2018

Michele Zorzetto

12

1 reference

27 March 2018

Simona Corso

object named as

Simona Corso

5

0 references

author name string

Giulia M Stella

1

1 reference

27 March 2018

Roberta Scabini

2

1 reference

27 March 2018

Francesca Cemmi

4

1 reference

27 March 2018

Ernesto Pozzi

6

1 reference

27 March 2018

Patrizia Morbini

7

1 reference

27 March 2018

Adele Valentini

8

1 reference

27 March 2018

Simona Ferrari

10

1 reference

27 March 2018

Maurizio Luisetti

11

1 reference

27 March 2018

publication date

5 May 2013

1 reference

27 March 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

27 March 2018

volume

139

1 reference

27 March 2018

issue

8

1 reference

27 March 2018

page(s)

1327-1335

1 reference

27 March 2018

Mutational analysis of the tyrosine kinome in colorectal cancers

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Computed tomography-guided core-needle biopsy specimens demonstrate epidermal growth factor receptor mutations in patients with non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

EGFR mutation detection in NSCLC--assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Targeting EGFR in non-small-cell lung cancer: lessons, experiences, strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1444-Y

Tyrosine kinases as targets for cancer therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23644698

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00432-013-1444-Y

1 reference

27 March 2018

1 reference

27 March 2018